Isoflurane USP 99.9 % Liquid is a Health Canada–registered veterinary drug (DIN 02237518) held by Fresenius Kabi Canada Ltd, containing Isoflurane. Health Canada lists its status as Marketed (status date 25 Feb 2015). Nexara Health has matched 85 registrations of Isoflurane across 21 other regulated markets.

Health Canada registration

Isoflurane registered in other markets

85 registrations of the same molecule in 21 national registries outside Canada (first 76 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Isoflurane worldwide →

Regulator price references for Isoflurane

Published list or reimbursement prices for Isoflurane presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Marketed Canadian products with the same active ingredient

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Isoflurane USP (DIN 02237518) marketed in Canada?

Yes. Health Canada lists DIN 02237518 as Marketed as of 25 Feb 2015.

Who holds the Canadian licence for this product?

Fresenius Kabi Canada Ltd is the company of record in the Health Canada Drug Product Database.

Is Isoflurane registered outside Canada?

Yes — Nexara Health has matched 85 registrations in 21 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02237518, status date 2015-02-25; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNOPS liste des medicaments, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02237518, status date 2015-02-25; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNOPS liste des medicaments, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, NHRA, SFDA.

Health Canada Drug Product Database (DPD), DIN 02237518, status date 2015-02-25; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNOPS liste des medicaments, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, Lyfjastofnun lyfjaverdskra, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.